AbbVie Inc. (ABBV) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Abbvie Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:01.694 Good morning, and thank you for standing by. 00:00:01.694 -- 00:00:06.421 Welcome to the AbbVie Third Quarter 2025 Earnings Conference Call. 00:00:06.421 -- 00:00:09.827 All participants will be able to listen only until the question and answer portion of 00:00:09.827 -- 00:00:13.753 this call. You may ask a question by pressing star 1 on your phone. 00:00:13.753 -- 00:00:17.519 Today's call is also being recorded. If you have any objections, you may disconnect at 00:00:17.519 -- 00:00:19.843 this time. I would now like to introduce Ms. 00:00:19.843 -- 00:00:22.667 Le Shea, Senior Vice President, Investor Relations. 00:00:22.667 -- 00:00:25.308 Thank you. You may begin. 00:00:25.492 -- 00:00:30.138 Good morning, and thanks for joining us. Also on the call with me today are Rob Michaels, 00:00:30.138 -- 00:00:35.044 Chairman and Chief Executive Officer, Jeff Stewart, Executive Vice President, Chief Commercial 00:00:35.044 -- 00:00:39.991 Officer, Rupal Thakkar, Executive Vice President, Research and Development, Chief Scientific 00:00:39.991 -- 00:00:44.918 Officer, and Scott Rents, Executive Vice President, Chief Financial Officer. 00:00:44.918 -- 00:00:48.623 Before we get started, I'll note that some statements we make today may be considered 00:00:48.623 -- 00:00:51.584 forward-looking statements based on our current expectations. 00:00:51.584 -- 00:00:55.189 Abby cautions that these forward-looking statements are subject to risks and uncertainties 00:00:55.189 -- 00:00:59.034 that may cause actual results to differ materially from those indicated in our forward-looking 00:00:59.034 -- 00:01:02.879 statements. Additional information about these risks and uncertainties is included in 00:01:02.879 -- 00:01:07.145 our SEC filings. ...